Refine my results

Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application

Schröder, Matthias ; Arlt, Olga ; Schmidt, Helmut ; Huwiler, Andrea ; Angioni, Carlo ; Pfeilschifter, Josef M. ; Schwiebs, Anja ; Radeke, Heinfried H.

In: Biological Chemistry, 2015, vol. 396, no. 6-7, p. 795-802

Uptake of reconstituted Na,K-ATPase vesicles by isolated lymphocytes measured by FACS, confocal microscopy and spectrofluorometry

Anner, Beatrice ; Volet, B.

In: Cell Biochemistry and Biophysics, 1999, vol. 30, no. 3, p. 437-454

Rapid turnover of the recirculating lymphocyte pool in vivo

Young, Alan J. ; Hay, John B. ; Miyasaka, M.

In: International Immunology, 1995, vol. 7, no. 10, p. 1607-1615

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma

Schilling, B. ; Sondermann, W. ; Zhao, F. ; Griewank, K. G. ; Livingstone, E. ; Sucker, A. ; Zelba, H. ; Weide, B. ; Trefzer, U. ; Wilhelm, T. ; Loquai, C. ; Berking, C. ; Hassel, J. ; Kähler, K. C. ; Utikal, J. ; Al Ghazal, P. ; Gutzmer, R. ; Goldinger, S. M. ; Zimmer, L. ; Paschen, A. ; Hillen, U. ; Schadendorf, D.

In: Annals of Oncology, 2014, vol. 25, no. 3, p. 747-753

Divergent Effect of Cobalt and Beryllium Salts on the Fate of Peripheral Blood Monocytes and T Lymphocytes

Paladini, Fabiana ; Cocco, Elisa ; Potolicchio, Ilaria ; Fazekasova, Henrieta ; Lombardi, Giovanna ; Fiorillo, Maria Teresa ; Sorrentino, Rosa

In: Toxicological Sciences, 2011, vol. 119, no. 2, p. 257-269

In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype

Anz, David ; Eiber, Stephan ; Scholz, Christoph ; Endres, Stefan ; Kirchner, Thomas ; Bourquin, Carole ; Mayr, Doris

In: Histopathology, 2011, vol. 59, no. 5, p. 965–974

Aims: Medullary breast cancer (MBC) is a biologically distinct subtype of breast cancer characterized by prominent lymphocytic infiltrates and a favourable clinical outcome. Tumour-infiltrating CD8+ effector T cells may contribute to the good prognosis of this type of cancer; however, certain subtypes of lymphocyte, such as FoxP3+ regulatory T cells (Tregs), can also suppress antitumour...